Bicycle Therapeutics (NASDAQ:BCYC) Stock: Insider Robert Charles Swanton Sells 3,431 Shares
MarketBeat
Bicycle Therapeutics PLC Sponsored ADR (NASDAQ:BCYC - Get Free Report) Director Robert Swanton sold 3,431 shares of Bicycle Therapeutics stock in a transaction on Friday, October 2nd. The shares were sold at an average price of $3.47, for a total value of $11,905.57. Following the completion of the sale, the director owned 15,782 shares in the company, valued at $54,763.54. This represents a 17.86% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
NASDAQ:BCYC
